journal article Aug 01, 2016

Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits

Canadian Journal of Cardiology Vol. 32 No. 8 pp. 1008.e1-1008.e10 · Elsevier BV
View at Publisher Save 10.1016/j.cjca.2015.09.022
Topics

No keywords indexed for this article. Browse by subject →

References
35
[1]
van Puijvelde "Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis" Circulation (2006) 10.1161/circulationaha.106.615609
[2]
van Puijvelde "Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis" Arterioscler Thromb Vasc Biol (2007) 10.1161/atvbaha.107.151274
[3]
George "Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I" Cardiovasc Res (2004) 10.1016/j.cardiores.2004.01.028
[4]
Klingenberg "Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis" Arterioscler Thromb Vasc Biol (2010) 10.1161/atvbaha.109.202671
[5]
Lu "Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice" Atherosclerosis (2010) 10.1016/j.atherosclerosis.2010.06.007
[6]
Mundkur "Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice" Int J Cardiol (2014) 10.1016/j.ijcard.2014.06.001
[7]
Lu "Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice" Atherosclerosis (2012)
[8]
Transgenic rabbits as therapeutic protein bioreactors and human disease models

Jianglin Fan, Teruo Watanabe

Pharmacology & Therapeutics 2003 10.1016/s0163-7258(03)00069-x
[9]
Aikawa "Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma" Circulation (2002) 10.1161/01.cir.0000028465.52694.9b
[10]
Bustos "HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis" J Am Coll Cardiol (1998) 10.1016/s0735-1097(98)00487-2
[11]
Mundkur "Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice" PLoS One (2013) 10.1371/journal.pone.0058364
[12]
Nesburn "Functional Foxp3+ CD4+ CD25(Bright+) “natural” regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection" J Virol (2007) 10.1128/jvi.00294-07
[13]
Boks "An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells" Scand J Immunol (2010) 10.1111/j.1365-3083.2010.02414.x
[14]
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism

Janine L. Coombes, Karima R.R. Siddiqui, Carolina V. Arancibia-Cárcamo et al.

The Journal of Experimental Medicine 2007 10.1084/jem.20070590
[15]
Sun "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid" J Exp Med (2007) 10.1084/jem.20070602
[16]
Nakajima-Adachi "Peyer's patches and mesenteric lymph nodes cooperatively promote enteropathy in a mouse model of food allergy" PLoS One (2014) 10.1371/journal.pone.0107492
[17]
Yoshino "Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization" Cell Immunol (1995) 10.1006/cimm.1995.1098
[18]
Torseth "Oral tolerance in experimental autoimmune uveoretinitis: feeding after disease induction is less protective than prefeeding" Clin Immunol Immunopathol (1998) 10.1006/clin.1998.4592
[19]
Hansson "Inflammation, atherosclerosis, and coronary artery disease" N Engl J Med (2005) 10.1056/nejmra043430
[20]
Libby "Inflammation in atherosclerosis" Arterioscler Thromb Vasc Biol (2012) 10.1161/atvbaha.108.179705
[21]
Johnson "A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice" Arterioscler Thromb Vasc Biol (2011) 10.1161/atvbaha.110.219147
[22]
Johnson "Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability" Cardiovasc Res (2006) 10.1016/j.cardiores.2006.05.009
[23]
Mallavia "Gene deficiency in activating Fcγ receptors influences the macrophage phenotypic balance and reduces atherosclerosis in mice" PLoS One (2013) 10.1371/journal.pone.0066754
[24]
Reimers "Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I" Cardiovasc Res (2011) 10.1093/cvr/cvr057
[25]
Randolph "Proliferating macrophages prevail in atherosclerosis" Nat Med (2013) 10.1038/nm.3316
[26]
Tabas "Macrophage death and defective inflammation resolution in atherosclerosis" Nat Rev Immunol (2010) 10.1038/nri2675
[27]
Tacke "Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques" J Clin Invest (2007) 10.1172/jci28549
[28]
He "CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells" Arterioscler Thromb Vasc Biol (2010) 10.1161/atvbaha.110.210492
[29]
Subramanian "Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs" J Clin Invest (2013) 10.1172/jci64617
[30]
Gautier "Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage" Circulation (2009) 10.1161/circulationaha.108.806158
[31]
Bjorkerud "Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability" Am J Pathol (1996)
[32]
Tabas "Macrophage apoptosis in advanced atherosclerosis" Ann N Y Acad Sci (2009)
[33]
Xia "Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice" PLoS One (2015) 10.1371/journal.pone.0123393
[34]
Lu "Integrin binding characteristics of the disintegrin-like domain of ADAM-15" Thromb Haemost (2006) 10.1160/th06-07-0395
[35]
Sasaki "Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice" Circulation (2009) 10.1161/circulationaha.109.863431
Metrics
5
Citations
35
References
Details
Published
Aug 01, 2016
Vol/Issue
32(8)
Pages
1008.e1-1008.e10
License
View
Funding
Garfield Weston Foundation
Cite This Article
Sheena Philip, Thiruvelselvan Ponnusamy, Lakshmi Narasimha Rao, et al. (2016). Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits. Canadian Journal of Cardiology, 32(8), 1008.e1-1008.e10. https://doi.org/10.1016/j.cjca.2015.09.022